JSCRX | VEXRX | JSCRX / VEXRX | |
Total Expense Ratio | 1.31 | 0.34 | 385% |
Annual Report Gross Expense Ratio | 1.56 | 0.34 | 459% |
Fund Existence | 21 years | 23 years | - |
Gain YTD | -13.162 | -13.374 | 98% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 50000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.76B | 19.8B | 14% |
Annual Yield % from dividends | 0.42 | 0.56 | 74% |
Returns for 1 year | -4.98 | -11.24 | 44% |
Returns for 3 years | -7.39 | -8.96 | 82% |
Returns for 5 years | 18.33 | 17.63 | 104% |
Returns for 10 years | -34.43 | 0.85 | -4,057% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XBI | 80.89 | 1.79 | +2.26% |
SPDR® S&P Biotech ETF | |||
FEP | 42.41 | 0.74 | +1.78% |
First Trust Europe AlphaDEX® ETF | |||
SBIO | 28.51 | 0.49 | +1.75% |
ALPS Medical Breakthroughs ETF | |||
BCDF | 28.98 | 0.44 | +1.54% |
Horizon Kinetics Blockchain Dev ETF | |||
CHI | 9.92 | 0.14 | +1.43% |
Calamos Convertible Opportunities and Income Fund |